Anavex Life Sciences: Weighing The Pros And Cons Of A Possible EU Approval Scenario
Anavex Life Sciences' (AVXL) stock surged on new Alzheimer's trial data, but data's inconsistency raises concerns, making the ...
Le Lézard5h
Invitation to presentation of BioArctic's third quarter report for July - September 2024 on November 14 at 9.30 a.m. CET
BioArctic AB (publ) will publish the company's third quarter report for July - September 2024 on Thursday, November 14, 2024, at 08:00 a.m. CET. In conjunction to the report, BioArctic invites ...